Cargando…
Cepharanthine Prevents Estrogen Deficiency-Induced Bone Loss by Inhibiting Bone Resorption
Osteoporosis is a common health problem worldwide caused by an imbalance of bone formation vs. bone resorption. However, current therapeutic approaches aimed at enhancing bone formation or suppressing bone resorption still have some limitations. In this study, we demonstrated for the first time that...
Autores principales: | Zhou, Chen-he, Meng, Jia-hong, Yang, Yu-te, Hu, Bin, Hong, Jian-qiao, Lv, Zheng-tao, Chen, Kun, Heng, Boon Chin, Jiang, Guang-yao, Zhu, Jian, Cheng, Zhao-hui, Zhang, Wei, Cao, Le, Wang, Wei, Shen, Wei-liang, Yan, Shi-gui, Wu, Hao-bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880888/ https://www.ncbi.nlm.nih.gov/pubmed/29636680 http://dx.doi.org/10.3389/fphar.2018.00210 |
Ejemplares similares
-
Boldine Ameliorates Estrogen Deficiency-Induced Bone Loss via Inhibiting Bone Resorption
por: Chen, Kun, et al.
Publicado: (2018) -
Micheliolide prevents estrogen deficiency-induced bone loss via inhibiting osteoclast bone resorption
por: Gan, Ziyang, et al.
Publicado: (2023) -
Sitagliptin, An Anti-diabetic Drug, Suppresses Estrogen Deficiency-Induced OsteoporosisIn Vivo and Inhibits RANKL-Induced Osteoclast Formation and Bone Resorption In Vitro
por: Wang, Chuandong, et al.
Publicado: (2017) -
TRPV6 is a potential regulator of bone resorption in bone loss induced by estrogen deficiency
por: Ma, Jun, et al.
Publicado: (2021) -
Editorial: Pharmacological mechanisms of drugs affecting bone formation and bone resorption
por: Zhang, Dongwei, et al.
Publicado: (2023)